Article Text

Download PDFPDF

O12.6 Contact tracing vs patient-delivered partner treatment for african american heterosexual men with chlamydia
Free
  1. Patricia Kissinger1,
  2. Norine Schmidt2,
  3. Gérard Gomes2,
  4. Glenis Scott2,
  5. Shannon Watson2,
  6. Megan Clare Craig-Kuhn2,
  7. Phazal Hines3,
  8. Sean Clark3,
  9. Javone Davis3,
  10. Alyssa Lederer4,
  11. David Martin2
  1. 1Tulane School of Public Health and Tropical Medicine, New Orleans, USA
  2. 2Tulane University School of Public Health and Tropical Medicine, Epidemiology, New Orleans, USA
  3. 3Louisiana Office of Public Health, HIV/STI, New Orleans, USA
  4. 4Tulane University School of Public Health and Tropical Medicine, Global Community Health and Behavior, New Orleans, USA

Abstract

Background Most research on partner treatment for chlamydia has been done with female index cases or with clinic-based populations, thus less is known about optimal approaches for community screened men. The purpose of this study is to compare contact-tracing versus patient-delivered partner-treatment (PDPT) for rates of index and partner treatment among chlamydia infected-young heterosexual African American men (AA) diagnosed by screening at community venues.

Methods ‘Check It’ is a community chlamydia screening program for AA men aged 15–24. Initially, index and partner treatment was done by a disease intervention specialist (DIS) using a contact-tracing approach where contacted index and partners could get azithromycin treatment at no cost at participating pharmacies. In month 14 of the program, in response to the findings of in-depth interviews with men enrolled in the program, contacted index men were offered PDPT that could be picked up at a participating pharmacy or mailed to the index. Index and partner treatment outcomes were compared.

Results In-depth interviews revealed concerns about giving DIS contact partner information and issues with transportation, thus, PDPT and direct-mailing of azithromycin were added to treatment options. There were 102 screened men in the contact-tracing-phase and 22 in the PDPT-phase. Of these 124 Ct+ men, 83.9% were contacted and 62.9% were treated and they reported 204 baseline partners. Treatment rates were higher in the PDPT-phase versus the contact-tracing-phase for index (86.4% vs 57.8%, p-value<0.02) and partners (50.0% vs 20.6%, p-value<0.01) respectively. Time-to-treatment was shorter for those in the PDPT-phase versus the contact-tracing-phase for index (10.7 vs 16.8 days, p <0.04). During the PDPT-phase 8/22 index men (36.4%) opted for mail-delivery of azithromycin.

Conclusion Expedited index and PDPT using local pharmacies or mailed-treatment resulted in significantly higher index and partner treatment rates and shorter time-to-treatment among AA young men screened for Ct in the community.

Disclosure No significant relationships.

  • chlamydia
  • partner treatment

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.